» Articles » PMID: 28283839

Selective Phosphodiesterase-2A Inhibitor Alleviates Radicular Inflammation and Mechanical Allodynia in Non-compressive Lumbar Disc Herniation Rats

Overview
Journal Eur Spine J
Specialty Orthopedics
Date 2017 Mar 12
PMID 28283839
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Phosphodiesterase inhibitors possess anti-inflammatory properties. In addition, some studies report that phosphodiesterase 2A (PDE2A) are highly expressed in the dorsal horn of the spinal cord. The present study aimed to investigate whether intrathecal administration of Bay 60-7550, a specific PDE2A inhibitor, could alleviate mechanical allodynia in non-compressive lumbar disc herniation (NCLDH) rats.

Methods: Rat NCLDH models by autologous nucleus pulposus implantation to dorsal root ganglion were established. Vehicle or Bay 60-7550 (0.1, 1.0 mg/kg) was injected by intrathecal catheter at day 1 post-operation. The ipsilateral mechanical withdrawal thresholds were analyzed from the day before surgery to day 7 after surgery. At day 7 post-operation, the ipsilateral lumbar (L4-L6) segments of the spinal dorsal horns were removed, and tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), cyclic adenosine monophosphate (cAMP), and cyclic guanosine monophosphate (cGMP) expressions were measured by ELISA. Furthermore, PDE2A mRNA and protein expressions in spinal cord were measured by Real-Time PCR and Western blot.

Results: Intrathecal administration of the PDE2A inhibitor Bay 60-7550, significantly attenuated mechanical allodynia, down-regulated spinal TNF-α, IL-1β and IL-6 over-expressions, increased the expression of spinal cAMP, as well as cGMP in a more remarkable manner, and decreased the spinal PDE2A expression in NCLDH rats in a dose-dependent manner.

Conclusions: Bay 60-7550 alleviated mechanical allodynia and inflammation in NCLDH rats, which might be associated with increased cAMP and especially cGMP increase. Thus, spinal PDE2A inhibition might represent a potential analgesic strategy for radiculopathy treatment in non-compressive lumbar disc herniation.

Citing Articles

Animal Models of Intervertebral Disc Diseases: Advantages, Limitations, and Future Directions.

Hong J, Kim H, Jeon W, Yeo C, Kim H, Lee J Neurol Int. 2024; 16(6):1788-1818.

PMID: 39728755 PMC: 11678881. DOI: 10.3390/neurolint16060129.


Evaluation of the effect of phellodendrin application on rats creating an experimental model of non-compression lumbar disc herniation on the NF-κB-related inflammatory signaling pathway.

Tan P, Mei J, Wang D J Orthop Surg Res. 2024; 19(1):816.

PMID: 39623500 PMC: 11613878. DOI: 10.1186/s13018-024-05313-7.


Upregulation of Phosphodiesterase 7A Contributes to Concurrent Pain and Depression via Inhibition of cAMP-PKA-CREB-BDNF Signaling and Neuroinflammation in the Hippocampus of Mice.

Chen S, Chen Y, Song Y, Zong S, Wu M, Wang W Int J Neuropsychopharmacol. 2024; 27(10).

PMID: 39283715 PMC: 11487153. DOI: 10.1093/ijnp/pyae040.


Thunder-fire moxibustion for lumbar disc herniation: A systematic review and meta-analysis.

Chen J, Luo Z, Liu M, Wang F, Zhou R, Wang Y Medicine (Baltimore). 2023; 101(49):e32270.

PMID: 36626497 PMC: 9750694. DOI: 10.1097/MD.0000000000032270.


Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders.

Delhaye S, Bardoni B Mol Psychiatry. 2021; 26(9):4570-4582.

PMID: 33414502 PMC: 8589663. DOI: 10.1038/s41380-020-00997-9.


References
1.
Gasser C, Taiber S, Yeh C, Wittig C, Hegemann P, Ryu S . Engineering of a red-light-activated human cAMP/cGMP-specific phosphodiesterase. Proc Natl Acad Sci U S A. 2014; 111(24):8803-8. PMC: 4066486. DOI: 10.1073/pnas.1321600111. View

2.
Gomez L, Breitenbucher J . PDE2 inhibition: potential for the treatment of cognitive disorders. Bioorg Med Chem Lett. 2013; 23(24):6522-7. DOI: 10.1016/j.bmcl.2013.10.014. View

3.
Wang L, Chopp M, Szalad A, Liu Z, Bolz M, Alvarez F . Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice. Neuroscience. 2011; 193:399-410. PMC: 3391742. DOI: 10.1016/j.neuroscience.2011.07.039. View

4.
Kallenborn-Gerhardt W, Lu R, Bothe A, Thomas D, Schlaudraff J, Lorenz J . Phosphodiesterase 2A localized in the spinal cord contributes to inflammatory pain processing. Anesthesiology. 2014; 121(2):372-82. DOI: 10.1097/ALN.0000000000000270. View

5.
Stephenson D, Coskran T, Kelly M, Kleiman R, Morton D, ONeill S . The distribution of phosphodiesterase 2A in the rat brain. Neuroscience. 2012; 226:145-55. PMC: 4409981. DOI: 10.1016/j.neuroscience.2012.09.011. View